Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00187850
Other study ID # 10002
Secondary ID
Status Completed
Phase N/A
First received September 13, 2005
Last updated October 14, 2016
Start date February 2005
Est. completion date June 2013

Study information

Verified date October 2016
Source University of Copenhagen
Contact n/a
Is FDA regulated No
Health authority Denmark: National Board of HealthSweden: Regional Ethical Review Board
Study type Interventional

Clinical Trial Summary

CAP-2 Trial

Background: This trial is being done in conjunction with an ongoing clinical trial investigating stepwise excavation versus final excavation on deep caries lesions (The CAP-1 trial). The investigators lack systematic knowledge concerning the treatment of the exposed pulp and whether the capping of a pulp represents the same outcome as the partial removal of an additional 1-1.5 mm of the pulp tissue (partial pulpotomy).

Aim: The aim of the CAP-2 trial is in a randomised clinical trial to investigate the effect of direct pulp capping versus partial pulpotomy in patients who, from the beginning, have received either a final excavation or a stepwise excavation and where this intervention has led to the exposure of a vital pulp and/or the patient has not gained relief from tooth pain after excavation and placement of a temporary restoration.

Patients: Patients include consecutive patients with deep caries who have been participating in the CAP-1 trial, where the pulp exposure to a bleeding pulp is present and/or pain relief has not been obtained.

Design: The CAP-2 trial is a randomised patient- and observer-blinded multicenter trial, with two parallel intervention groups. Patients who fulfill the inclusion criteria will be centrally bloc-randomised in the Copenhagen Trial Unit, Copenhagen DK, and stratified by age and pain. The allocation ratio is 1:1.

The Interventions and Products: Patients are allocated for direct pulp capping or partial pulpotomy. The patients will not be informed about the results of the randomisation, i.e. the type of intervention. In both groups the patient receives a calcium hydroxide seal covering the exposure and a glass ionomer restoration. The final resin restoration is placed following 4 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date June 2013
Est. primary completion date March 2007
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Persons participating in the CAP-1 trial, who have received a pulp exposure due to treatment or due to absence of pain relief.

Exclusion Criteria:

- The CAP-1-treated tooth has ongoing unbearable pain and/or disturbed night sleep.

- Visible pus from the pulp.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
PP
Partial pulpotomy
DPC
Direct pulp capping

Locations

Country Name City State
Denmark Copenhagen University Copenhagen Copenhagen N

Sponsors (8)

Lead Sponsor Collaborator
University of Copenhagen Dan Dental A/S, Göteborg University, Huddinge Faculty,Stockholm,Sweden, Malmö Dental school,Sweden, National Health Insurance foundation, University of Aarhus, Uppsala FolkTandvård,Sweden

Country where clinical trial is conducted

Denmark, 

References & Publications (1)

Bjørndal L, Reit C, Bruun G, Markvart M, Kjaeldgaard M, Näsman P, Thordrup M, Dige I, Nyvad B, Fransson H, Lager A, Ericson D, Petersson K, Olsson J, Santimano EM, Wennström A, Winkel P, Gluud C. Treatment of deep caries lesions in adults: randomized clinical trials comparing stepwise vs. direct complete excavation, and direct pulp capping vs. partial pulpotomy. Eur J Oral Sci. 2010 Jun;118(3):290-7. doi: 10.1111/j.1600-0722.2010.00731.x. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The survival of the tooth with vital pulp and without apical radiolucency. The x-ray evaluation and the clinical sensibility test are carried out by a blinded observer. 1 year after inclusion in the CAP-2 No
Secondary Gain of pain relief after 4 weeks No
See also
  Status Clinical Trial Phase
Completed NCT02019563 - MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial Phase 2
Completed NCT00812877 - Pulp Capping With Two Different Agents N/A
Not yet recruiting NCT04330768 - Platelet Rich Fibrin(PRF) Injection for Treatment of Dental Pulp Exposure:Randomized Clinical Trial N/A
Completed NCT02789423 - Clinical & Radiographical Evaluation of the Effect of Dycal & Biodentine in DPC in Primary Teeth N/A
Completed NCT01468480 - Human Pulpal Response After Pulp Capping With Four Different Agents Phase 2/Phase 3
Completed NCT02487329 - The Effect of Laser Combined With Pulp-capping Agents on Direct Pulp Capping N/A
Completed NCT03631511 - Histological Evaluation of Hard Tissue Formation After Direct Pulp Capping With RetroMTA N/A
Completed NCT02492841 - Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth Phase 2/Phase 3